跳轉至內容
Merck
全部照片(1)

重要文件

616454

Sigma-Aldrich

A 83-01

≥97% (HPLC), solid, TGF-β RI kinase inhibitor, Calbiochem

同義詞:

TGF-β RI 激酶抑制剂 IV

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C25H19N5S
CAS號碼:
分子量::
421.52
MDL號碼:
分類程式碼代碼:
12352200
NACRES:
NA.54
暫時無法取得訂價和供貨情況

產品名稱

TGF-β RI 激酶抑制剂 IV, TGF-β RI Kinase Inhibitor IV, CAS 909910-43-6, is a cell-permeable, selective inhibitor of ALK-4/5/7-mediated signaling (IC₅₀ = 45, 12, and 7.5 nM, respectively).

品質等級

化驗

≥97% (HPLC)

形狀

solid

製造商/商標名

Calbiochem®

儲存條件

OK to freeze
protect from light

顏色

pale yellow

溶解度

DMSO: 20 mg/mL

運輸包裝

ambient

儲存溫度

2-8°C

SMILES 字串

S=C([n]2nc(c(c2)c4c5c(ncc4)cccc5)c3nc(ccc3)C)Nc1ccccc1

InChI

1S/C25H19N5S/c1-17-8-7-13-23(27-17)24-21(19-14-15-26-22-12-6-5-11-20(19)22)16-30(29-24)25(31)28-18-9-3-2-4-10-18/h2-16H,1H3,(H,28,31)

InChI 密鑰

HIJMSZGHKQPPJS-UHFFFAOYSA-N

一般說明

一种细胞渗透性三取代吡唑化合物,已显示在表达单个I型TGF-β受体的Mv1Lu R4-2转染子中选择性抑制ALK-4/5/7介导(荧光素酶转录活性测定中IC50分别为45、12和7.5 nM),但不抑制ALK-1/2/3/6介导的细胞信号。在浓度为1 µM的情况下,抑制HaCaT细胞中TGF-β-诱导的Smad2磷酸化和NMuMG细胞中的上皮间质转化。

生化/生理作用

主要靶标
ALK-4/5/7
产物不与ATP竞争。
可逆:否
细胞可渗透性:是
靶标IC50:抑制ALK-4/5/7介导的荧光素酶转录活性测定分别为45、12和7.5 nM

包裝

用惰性气体包装

警告

毒性:有害(C)

重構

复溶后,等分并冷冻保存(-20°C)。贮备溶液在-20°C下可稳定保存至多3个月。

其他說明

Tojo, M., et al. 2005.Cancer Sci.96, 791.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

Felix Kretzschmar et al.
Biology, 10(12) (2021-12-25)
As resident innate immune cells of the CNS, microglia play important essential roles during physiological and pathological situations. Recent reports have described the expression of Lilrb4 in disease-associated and aged microglia. Here, we characterized the expression of Lilrb4 in microglia
Fabian Trillsch et al.
STAR protocols, 4(3), 102484-102484 (2023-08-16)
We present a protocol for effective biobanking of epithelial ovarian cancer organoids, considering the heterogeneous clinical presentation and high recurrence rates. Our protocol involves parallel testing of three media to identify patient-specific optimal conditions. We describe steps for tissue dissociation
Alexander von Ehr et al.
Frontiers in cellular neuroscience, 14, 66-66 (2020-04-17)
Microglia are constantly surveying their microenvironment and rapidly react to impairments by changing their morphology, migrating toward stimuli and adopting gene expression profiles characterizing their activated state. The increased expression of the M2-like marker Mannose receptor 1 (Mrc1), which is
Erin R Spiller et al.
Frontiers in oncology, 11, 771173-771173 (2022-01-08)
Three-quarters of compounds that enter clinical trials fail to make it to market due to safety or efficacy concerns. This statistic strongly suggests a need for better screening methods that result in improved translatability of compounds during the preclinical testing
Naveen Kumar et al.
Nature communications, 15(1), 3064-3064 (2024-04-10)
The gastroesophageal squamocolumnar junction (GE-SCJ) is a critical tissue interface between the esophagus and stomach, with significant relevance in the pathophysiology of gastrointestinal diseases. Despite this, the molecular mechanisms underlying GE-SCJ development remain unclear. Using single-cell transcriptomics, organoids, and spatial

Questions

  1. How can I store this molecule in its lyophilized form and how stable is it?

    1 answer
    1. In the lyophilized form, this product is stored refrigerated at 2 - 8°C. This item is assigned a retest date, which is reported on the lot-specific Certificate of Analysis. Upon reconstitution at 20 mg/mL in DMSO, aliquot and store the solution at -20°C, protected from light, for up to 3 months.

      Helpful?

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務